Nucleosyn
  • Home
  • Products
    • All products
    • Products categories
    • DNA-RNA
    • Synthetic lipids
    • Stable isotope
    • Custom chemical synthesis
  • Capabilities
  • About Us
  • Contact
  • Linkedin

My selection

DNA-RNA

Nuleosyn offers an extensive line of standard phosphoramidites, RNA phosphoramidites, specialty amidites and modifiers, solid supports CPG, reagents and solvents for a wide variety of instruments

2'-DeoxyInosine phosphoramidite

CAS #
141684-35-7
Packing size
100µmol, 250mg
Synonyme(s)
dI
DeoxyinosineDeoxyribosePhosphoramiditeDNA & RNA SupportsDNA & RNA AnalogsDNA & RNA Nucleosides
2'-DeoxyInosine phosphoramidite Image 1

2'-DeoxyInosine phosphoramidite (dI) is a novel, modified nucleoside monophosphate. It is an activator of antiviral and anticancer activities.

Aspect
White solid
Purity
>95%
Solubility
Dichloromethane, EtOAc, MeCN
Molecular weight
554,60
Molecular formula

C40H47N6O7P

IUPAC
(2R,3S,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

R. Iwaura, Chem. Eur. J., 2019, 25, 2281-2287. read article

Y. Li, P. Zhao, M. Zhang, X. Zhao, X. Li, J. Am. Chem. Soc., 2013, 135, 17727-17730. read article

Purchase 2'-DeoxyInosine phosphoramidite

Get a quote on this product

We're ready to solve any rare chemicals sourcing or molecular design problem... Give us a shout! Please fill out this form completely.

If you don't find a product in our current offer, please don't hesitate to request a quote using our contact form.

Add to my selection

Related products

5'-Amino-Modifier C6 (C6-MMT)
CAS #
114616-27-2
Details
5'-Amino-Modifier C6-TFA
CAS #
133975-85-6
Details
5'-Biotin phosphoramidite
CAS #
135137-87-0
Details
See more products

logo footerNucleosyn

111 Bd Duhamel du Monceau

45160 Olivet

Products

See Catalog

Know more about products

Contact

Contact Form

+33 2 38 49 45 73

Follow us

Other Infos

Legal notices

Privacy Policy & cookies infos

General terms & conditions

© Nucleosyn 2025 - All rights reserved

Design and development Think Ad Communication